rs755954919
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_000245.4(MET):c.799G>A(p.Glu267Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000157 in 1,461,806 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000245.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MET | NM_000245.4 | c.799G>A | p.Glu267Lys | missense_variant | Exon 2 of 21 | ENST00000397752.8 | NP_000236.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MET | ENST00000397752.8 | c.799G>A | p.Glu267Lys | missense_variant | Exon 2 of 21 | 1 | NM_000245.4 | ENSP00000380860.3 | ||
MET | ENST00000318493.11 | c.799G>A | p.Glu267Lys | missense_variant | Exon 2 of 21 | 1 | ENSP00000317272.6 | |||
MET | ENST00000436117.3 | n.799G>A | non_coding_transcript_exon_variant | Exon 2 of 20 | 1 | ENSP00000410980.2 | ||||
MET | ENST00000422097.2 | c.799G>A | p.Glu267Lys | missense_variant | Exon 2 of 12 | 3 | ENSP00000398776.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 249054Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135088
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461806Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 727208
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Autosomal recessive nonsyndromic hearing loss 97 Uncertain:1
- -
Papillary renal cell carcinoma type 1;C2239176:Hepatocellular carcinoma;C4084709:Autosomal recessive nonsyndromic hearing loss 97;C4085248:Osteofibrous dysplasia Uncertain:1
- -
Renal cell carcinoma Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 267 of the MET protein (p.Glu267Lys). This variant is present in population databases (rs755954919, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with MET-related conditions. ClinVar contains an entry for this variant (Variation ID: 411894). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MET protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.E267K variant (also known as c.799G>A), located in coding exon 1 of the MET gene, results from a G to A substitution at nucleotide position 799. The glutamic acid at codon 267 is replaced by lysine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at